Biosimilarity: The FDA Perspective - CRC Press Book - Image 1

£88.96

CRC Press Biosimilarity: The FDA Perspective - CRC Press Book

Name: Biosimilarity: The FDA Perspective - CRC Press Book
Brand: CRC Press
Price: 88.96 GBP
Availability: InStock

Biomedical Engineering

About as cheap as it gets. The only time it was cheaper was 1 month ago.

£89 today · all-time low £87 (Jun 2026) · usually £89

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 82 days · 82 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 82 days • 4 price levels

Days at Price

Current Price

Price Analysis

Most common price: £88 (32 days, 39.0%)

Price range: £87 - £90

Price levels: 4 different prices over 82 days

Description

Navigate the complex landscape of biological drug approval with Biosimilarity: The FDA Perspective. Published by CRC Press, this book offers a deep look into how the U.S. FDA approaches the approval process for biosimilar drugs. By analyzing recent FDA approvals, it provides a practical guide for understanding the regulatory environment. This resource explains how to use statutory limits and non-inferiority testing to help avoid unnecessary patient trials and reduce the need for extensive immunogenicity testing. It provides the mathematical and statistical foundations necessary to establish biosimilarity across various levels of biological complexity. Whether you are a researcher or a developer, this text serves as a vital technical resource for meeting modern regulatory standards and understanding the scientific tools required for successful drug development.

Key Features

Provides a comprehensive analysis based on the latest FDA guidelines and recent approval packages.

Explains how to use non-inferiority testing and statutory limits to minimize the need for patient trials.

Offers an in-depth scientific and mathematical view of the tools required to establish biosimilarity.

Covers the statistical methods needed to manage biological drugs of different complexity levels.

Delivers practical insights learned directly from recent U.S. FDA drug approval processes.

Product Specifications

Brand: CRC Press
Format: hardcover
ASIN: 1498750397
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Biomedical Engineering
Domain: Amazon UK
Release Date: 04 August 2016
Listed Since: 04 November 2015

Barcode

No barcode data available

CRC Press Biosimilarity: The FDA Perspective - CRC Press Book

About as cheap as it gets. The only time it was cheaper was 1 month ago.

Price History & Forecast

Price Distribution

Price Analysis

Description

Key Features

Product Specifications

Barcode

Similar Products You Might Like

Biosimilars and Interchangeable Biologics: Strategic Elements

Biosimilars Development Strategies: Fast to Market Approaches

Biosimilars and Interchangeable Biologics: Tactical Elements

Biosimilars and Interchangeable Biologics: Strategic Elements

Biosimilars and Interchangeable Biologics: Tactical Elements

Biosimilars: A New Generation of Biologics

Biosimilars: A New Generation of Biologics

CRC Press - Biosimilar Drug Product Development Book

ASHP Biosimilars and Biologics - Implementation and Monitoring

Biosimilar and Interchangeable Biologics: From Cell Line to Commercial Launch, Two Volume Set

Nonclinical Development of Novel Biologics, Biosimilars and Specialty Biologics

Biosimilar Drug Product Development (Drugs and the Pharmaceutical Sciences)

Biologics and Biosimilars: Drug Discovery and Clinical Applications

Biosimilar Clinical Development: Scientific Considerations and New Methodologies (Chapman & Hall/CRC Biostatistics Series)

Commercialization of BioPharma Products in the USA (BW): A Practical Guide

Biologics, Biosimilars, and Biobetters: An Introduction for Pharmacists, Physicians and Other Health Practitioners

Analytical Similarity Assessment in Biosimilar Product Development

Follow-On Biologics: Background & Issues (Biotechnology in Agriculture Industry and Medicine)

Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)

Artificial Intelligence for Drug Product Lifecycle Applications

Biopharmaceutical Supply Chains: Distribution, Regulatory, Systems and Structural Changes Ahead

Mastering Strategic Marketing For Specialty Pharmaceuticals: A Hands-on Guide

Development and Evaluation of Drugs: From Laboratory through Licensure to Market

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals